Analysed OLEMA PHARMACEUTICALS INC (OLMA:NASDAQ) News Sources
The Zacks Analyst Blog Highlights AstraZeneca, Roche, Puma Biotechnology and Olema Oncology
19-10-2026
yahoo.com
ESR1-Mutated Metastatic Breast Cancer Market Expected to Grow Rapidly at 9.6% CAGR During the Forecast Period (2026–2036) Due to the Emergence of Novel Oral SERDs and Targeted Agents | DelveInsight
20-05-2026
yahoo.com
SERD Market Set for Growth During the Forecast Period (2026-2036) as AstraZeneca's ETCAMAH Approval Accelerates Adoption of Oral SERDs | DelveInsight
05-10-2026
yahoo.com
Olema Oncology Announces Encouraging Initial Clinical Data from the Phase 1 Study of OP-3136, a KAT6 Inhibitor, at 2026 ASCO Annual Meeting
21-05-2026
yahoo.com
Does Olema Pharmaceuticals' (OLMA) Broad Russell Growth Inclusion Reveal a Turning Point in Its Investor Story?
30-06-2026
yahoo.com
Olema Pharmaceuticals Shares Fall 15.1% Following AstraZeneca SERENA-4 Trial Results
14-09-2026
advfn.com
What is the current price of OLEMA PHARMACEUTICALS INC (OLMA:NASDAQ)?
The current price of OLEMA PHARMACEUTICALS INC (OLMA:NASDAQ) is $7.
OLEMA PHARMACEUTICALS INC (OLMA:NASDAQ) absolute price change since previous trading day?
The absolute price change of OLEMA PHARMACEUTICALS INC (OLMA:NASDAQ) since the previous trading day is $-0.33.
OLEMA PHARMACEUTICALS INC (OLMA:NASDAQ) percentage price change since previous trading day?
The percentage price change of OLEMA PHARMACEUTICALS INC (OLMA:NASDAQ) since the previous trading day is -4.502%.
What is the most recent average sentiment score for OLEMA PHARMACEUTICALS INC (OLMA:NASDAQ)?
The most recent average sentiment score for OLEMA PHARMACEUTICALS INC (OLMA:NASDAQ) is 89 out of 100.
What is the most recent average sentiment for OLEMA PHARMACEUTICALS INC (OLMA:NASDAQ)?
The most recent sentiment for OLEMA PHARMACEUTICALS INC (OLMA:NASDAQ) is .
SEC-8K** Filing Available For OLEMA PHARMACEUTICALS INC (OLMA:NASDAQ)
** material developments that could impact a company's financial condition or stock price.
Author: MattELab
MattELab is the founder and lead developer of SentientMerchant. With a Computer Science and Quantitative Finance background from a T10 university, he brings over 6 years of expertise in NLP, programmatic SEO, and full-stack development to build highly scalable AI and FinTech solutions.